You Searched For "gilead sciences remdesivir" and got 20 results
Sort By:
1 min read
Batches of the COVID-19 treatment drug Remdesivir were recalled after glass particles were found in some vials
Biopharmaceutical company Gilead Sciences announced that two lots of Remdesivir are being recalled …
Cheryl Teh
2 mins read
Gilead rises after pricing its coronavirus-fighting drug remdesivir
"We believe that pricing remdesivir well below value is the right and responsible thing to do," sai…
Carmen Reinicke
2 mins read
FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients
Following an evaluation of the emergency use authorization criteria and scientific evidence a…
PTI
2 mins read
Remdesivir linked to reduced risk of death in severe Covid-19 patients
This is an important finding that requires confirmation in prospective clinical trials, Gilead s…
4 mins read
What it'll take to get a vaccine to Americans
These are the top stories written by Business Insider's healthcare team for the week ending October…
Lydia Ramsey Pflanzer
2 mins read
Gilead's remdesivir just got the first FDA approval to be used as a treatment for coronavirus patients
Gilead Sciences just received approval from the US Food and Drug Administration to use its antivira…
Allana Akhtar
2 mins read
See the pitch deck a healthcare startup founded by 2 ex-Googlers used to raise $47 million
These are Business Insider's biggest healthcare stories for October 19.
Lydia Ramsey Pflanzer
4 mins read
The federal government finally announced initial plans to distribute Gilead's coronavirus drug remdesivir after days of confusion
The government said it's distributing the promising coronavirus drug, remdesivir, to some hard-hit …
Anna Medaris Miller
5 mins read
Trump's doctors are targeting a 'sweet spot' in fighting COVID-19 by using experimental treatments early, but physicians caution the data is limited
"We are clearly in a data-free zone right here," an infectious-disease physician told Business Insi…
Andrew Dunn
3 mins read
The US bought up 90% of the world's supply of remdesivir for the next 3 months, and patents mean many countries won't be able to get any
Gilead Sciences will sell almost all of the world's supply of remdesivir to the US for the next thr…
Mia Jankowicz
3 mins read
The $96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients
If the inhaled version of remdesivir works, it "could have significant implications in helping to s…
Andrew Dunn
2 mins read
Gilead sets a price for its coronavirus treatment — Pfizer's newest digital health bet — Reopenings reversed
These are the top stories written by Business Insider's healthcare team for June 30.
Lydia Ramsey Pflanzer
2 mins read
The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it's charging up to $520 a vial for remdesivir
Governments of developed countries will pay $2,340 for a five-day course of the antiviral drug remd…
Andrew Dunn
2 mins read
EXCLUSIVE: See the presentation Cedar used to convince investors like Andreessen Horowitz to invest $102 million
These are the top stories written by Business Insider's healthcare team for Tuesday, June 23.
Lydia Ramsey Pflanzer
3 mins read
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
The nonprofit group often finds drugs to be overpriced. For the first potential COVID-19 drug, it s…
Andrew Dunn
6 mins read
Dispensed: A week of drug developments, the plan to restart hospitals, and some non-coronavirus news
Welcome to Dispensed, BI's weekly healthcare newsletter. This week, the TLDR on remdesivir, a promi…
Lydia Ramsey
1 min read
Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug
One of the most promising coronavirus treatment candidates succeeded in a late-stage trial in COVID…
Andrew Dunn
1 min read
Study results for a leading potential coronavirus treatment were accidentally released by the WHO and then taken down
About 14% of severe coronavirus patients taking the drug remdesivir died compared to 13% who got a …
Andrew Dunn
3 mins read
Hospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK'd its emergency use
Some hospitals are having a hard time getting remdesivir for their patients. The government is deci…
Lydia Ramsey,Andrew Dunn
3 mins read
US health authorities are reportedly preparing to allow emergency use of Gilead's antiviral remdesivir to treat coronavirus patients, following positive study results
FDA is reportedly preparing to allow emergency use of remdesivir as soon as today. The treatment he…